Pharmetheus at PAGE 2023

Are you a student in need of input or expert advise, or are you representing a life-sciences business wanting confidential consulting - don't hesitate to get in touch online or at our booth. Here's Pharmetheus contributions to the program during the conference.

Monday 26 June

Workshop: ‘PBPK-PD/QSP modeling with the OSPSuite (PK-Sim®, MoBi®)’

Interested in combining PBPK and PD/QSP models and looking for efficient means to accomplish this? Join this workshop led by Pharmetheus’ experts and held on Monday-Tuesday 26th-27th of June 2023 (09:00-17:00 CEST/GMT+1), in connection to PAGE in A Coruña, Spain.

Read more

Tuesday 27 June

Workshop: ‘PBPK-PD/QSP modeling with the OSPSuite (PK-Sim®, MoBi®)’

Interested in combining PBPK and PD/QSP models and looking for efficient means to accomplish this? Join this workshop led by Pharmetheus’ experts and held on Monday-Tuesday 26th-27th of June 2023 (09:00-17:00 CEST/GMT+1), in connection to PAGE in A Coruña, Spain.

Read more

Workshop: An introduction to probabilistic decisions support in drug development

Are you looking to improve decision making in drug development? This workshop introduces how Model-Informed-Drug-Development (MIDD) principles can be applied to facilitate probability-based decision making in drug development. Pharmetheus host this satellite workshop on the 25th of June in conjunction to PAGE.

Read more

Educational Pharmacometrics Summer Symposium (EPSS) with Boehringer- Ingelheim and University of Navarra

Boehringer Ingelheim, Pharmetheus and University of Navarra are supporting the second Educational Pharmacometrics Summer Symposium, which will take place at the University of A Coruña, on the 27 June 2023.

Read more

Wednesday 28 June

Session “New modeling approaches”, 09.00-10.00


Chair

Poster session I, 10.00-11.30


Poster presentation

Population PK analysis Pega Spargase in Japanese and non-Japanese patients with acute lymphoblastic leukemia

Poster session II, 15.35-17.00


Poster presentation

Physiologically based pharmacokinetic (PBPK) modeling of the oral absorption of 5-flucytosine to support further development of a sustained-release formulation for the treatment of Cryptococcal Meningoencephalitis

Poster presentation

Use of informative prior distributions from mepolizumab data to support depemokimab PKPD model analysis

Session “A tutorial on machine learning & pharmacometrics”, 14.00-14.50


Chair

Session “Machine learning in pharmacometrics” 14.50-15.30

Chair

Thursday 29 June

Poster session III, 10.15-11.45:


Poster presentation

Mechanistic modeling of bioavailability and local immunogenisity after subcutaneous administration within the Open Systems Pharmacology framework

Poster presentation

Application of tumor size modeling and simulations to support the dose selection for a phase II study

Keynote lecture, 13.55-14.40

Chair

Session “Tumor growth dynamics”, 14.40-15.20

Chair

Poster session IV, 15.25-16.55


Poster presentation

Target engagement analysis of belimumab in patients with systemic lupus erythematosus (SLE) and primary Sjogrens syndrom (pSS)

Friday 30 June

Session “Model diagnostics”, 10.55-11.55

Chair

Oral presentation 10.55

Application relevant shrinkage metrics